Cyclacel Pharmaceuticals, Inc. (BGMS)
NASDAQ
Cyclacel Pharmaceuticals, Inc. Revenue 2009–2025
Cyclacel Pharmaceuticals, Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Cyclacel Pharmaceuticals, Inc. revenue for the quarter ending March 31, 2026 was 743000, a 2462.07% increase year-over-year.
- Cyclacel Pharmaceuticals, Inc. revenue for the twelve months ending March 31, 2026 was 838000, a 100.48% increase year-over-year.
- Cyclacel Pharmaceuticals, Inc. annual revenue for 2025 was 0, a 100.00% decrease from 2024.
- Cyclacel Pharmaceuticals, Inc. annual revenue for 2024 was 43000, a 89.76% decrease from 2023.
- Cyclacel Pharmaceuticals, Inc. annual revenue for 2023 was 420000.
- Cyclacel Pharmaceuticals, Inc. annual revenue for 2022 was 0.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cyclacel Pharmaceuticals, Inc. Market Cap — FAQ
Cyclacel Pharmaceuticals, Inc. (BGMS) market cap over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BGMS's market cap history?
The chart and table above show Cyclacel Pharmaceuticals, Inc.'s market cap by year and by quarter, including the growth rate.